Preferred Label : antagonists and inhibitors;

MeSH synonym : antagonists & inhibitors; antagonists; inhibitors;

Details


Main resources

You can consult :


http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Risques-hemorragique-et-thromboembolique-associes-a-la-double-anticoagulation-par-AVK-et-heparinotherapie-HBPM-lors-de-l-initiation-de-l-AVK-dans-la-fibrillation-auriculaire-sans-complication-les-resultats-d-une-etude-de-l-ANSM-Point-d-Information
2017
false
false
false
France
French
pharmacovigilance note
risk assessment
atrial fibrillation
heparin, low-molecular-weight
vitamin K
antivitamins K
hemorrhage
stroke
drug therapy, combination
anticoagulants
embolism
thromboembolism
administration, oral
injections, subcutaneous
indenes
4-hydroxycoumarins

---
http://kce.fgov.be/fr/publication/report/anticoagulation-et-fibrillation-auriculaire
2017
false
false
false
Belgium
French
anticoagulants
anticoagulants
atrial fibrillation
treatment outcome
stroke
continuity of patient care
Cost-Benefit analysis
medication adherence
risk assessment
hemorrhage
vitamin K
antivitamins K
Rivaroxaban
edoxaban
Dabigatran
apixaban
Factor Xa Inhibitors
antithrombins
belgium
technical report
drug information
comparative study
anticoagulants
economic evaluation
drug monitoring
new oral anticoagulant
indenes
4-hydroxycoumarins
pyridines
thiazoles
pyrazoles
pyridones

---
http://www.cochrane.org/fr/CD002021
2017
false
true
false
France
analgesics, opioid
opioid-related disorders
treatment outcome
conscious sedation
Opioid withdrawal
review of literature
french abstract

---
http://www.cochrane.org/fr/CD002001/les-antagonistes-de-la-vitamine-k-ou-lheparine-de-bas-poids-moleculaire-pour-le-traitement-long
2017
false
France
French
anticoagulotherapy
meta-analysis
vitamin K
heparin, low-molecular-weight
anticoagulants
fibrinolytic agents
venous thromboembolism
treatment outcome
french abstract

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Fluindione-Previscan-R-mises-en-garde-sur-le-risque-d-effets-indesirables-immuno-allergiques-Lettre-aux-professionnels-de-sante
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Previscan-fluindione-et-risque-immuno-allergique-Point-d-Information
2017
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
administration, oral
fluindione
continuity of patient care
fluindione
france
vitamin K
antivitamins K
anticoagulants
drug hypersensitivity
kidney function tests
liver function tests
hematologic tests
skin manifestations
phenindione
phenindione
indenes
4-hydroxycoumarins

---
Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the Potential Risk of Bone-Related Side Effects
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/sglt2-3-fra.php
2016
false
false
false
Canada
French
English
Canagliflozin
hypoglycemic agents
dapagliflozin
Sodium-Glucose transporter 2
SGLT2 Inhibitor
risk assessment
drug evaluation
empagliflozin
adult
diabetes mellitus, type 2
fractures, bone
bone demineralization, pathologic
bone and bones
pharmacovigilance note
product surveillance, postmarketing
canada
dapagliflozin
canagliflozin
empagliflozin
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
benzhydryl compounds
glucosides

---
Summary Safety Review - Tumour Necrosis Factor (TNF) alpha blockers (SIMPONI and CIMZIA) - Assessing the Potential Risk of Liver Inflammation (Autoimmune Hepatitis)
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tnf-fnt-2-fra.php
2016
false
false
false
Canada
French
tumor necrosis factor-alpha
drug evaluation
risk assessment
hepatitis, autoimmune
canada
tumor necrosis factor alpha (tnf-alpha) inhibitors
psoriasis
arthritis, rheumatoid
crohn disease
colitis, ulcerative
golimumab
Certolizumab Pegol
antibodies, monoclonal

---
http://www.has-sante.fr/portail/jcms/c_2729222/fr/quelle-place-pour-la-transfusion-des-plasmas-therapeutiques
2016
false
false
false
France
French
plasma
guidelines for drug use
fresh frozen plasma
hemorrhage
shock, hemorrhagic
blood component transfusion
disseminated intravascular coagulation
prothrombin level abnormal
thrombotic microangiopathies
infant, newborn
child
adult
pregnancy
antivitamins K
anticoagulant overdosage, nos
cardiac surgical procedures
coagulation protein disorders
neurosurgical procedures
blood component transfusion
blood component transfusion
blood plasma
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
SGLT2 inhibitors
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-fra.php#sglt2
2016
false
false
false
Canada
French
English
drug evaluation
SGLT2 Inhibitor
Sodium-Glucose transporter 2
Canagliflozin
hypoglycemic agents
risk assessment
dapagliflozin
empagliflozin
diabetes mellitus, type 2
fractures, bone
bone demineralization, pathologic
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
glucosides
benzhydryl compounds

---
http://www.inrs.fr/media.html?refINRS=TF%20241
2016
false
false
false
France
French
review of literature
legionellosis
Anti-Tumor Necrosis Factor Therapy
tumor necrosis factors
occupational exposure
risk
occupational diseases
occupational diseases
legionellosis
continuity of patient care
occupational medicine
pontiac fever
occupational diseases
legionellosis
risk assessment
anti-TNF

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antagonistes-de-la-vitamine-k-avk
2016
false
false
false
France
French
antivitamins K
drug information
anticoagulants
vitamin K
antivitamins K
vitamin k, nos
indenes
4-hydroxycoumarins
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://www.revmed.ch/RMS/2016/RMS-N-509/Spondyloarthropathies-traitements-conventionnels-et-anti-TNF
2016
false
false
false
Switzerland
French
journal article
spondylarthropathies
anti-inflammatory agents, non-steroidal
tumor necrosis factors
anti-TNF

---
http://www.cochrane.org/fr/CD003424/medicaments-destines-reduire-lacidite-gastrique-chez-les-personnes-atteintes-de-mucoviscidose
2016
false
France
French
review of literature
cystic fibrosis
treatment outcome
gastric acidity, nos
gastric acid
gastrointestinal agents
histamine h2 antagonists
proton pumps
french abstract

---
http://www.centreantipoisons.be/professionnels-de-la-sant/articles-pour-professionnels-de-la-sant/intoxications-aigu-s-et-antidote-4
false
true
false
Belgium
patient education handout
flumazenil
antidotes
benzodiazepines

---
http://www.centreantipoisons.be/professionnels-de-la-sant/articles-pour-professionnels-de-la-sant/intoxications-aigu-s-et-antidot-15
false
true
false
Belgium
patient education handout
vitamin K

---
http://www.cfp.ca/content/62/1/e11.full
http://www.cfp.ca/content/62/1/e11.full.pdf+html
2016
false
false
false
Canada
French
journal article
celiac disease
serologic tests
general practice
case reports
child
celiac disease
transglutaminases
immunoglobulin A
Anti-transglutaminase antibody
general practitioners

---
http://www.mongeneraliste.be/fichespatients/anti-vitamines-k-ou-avk
2016
false
true
false
false
Belgium
French
popular works
vitamin K
anticoagulants
antivitamins K

---
In : Bulletin du Cancer Volume 103, Issue 2, February 2016, Pages 180–189 - Open Access
http://www.sciencedirect.com/science/article/pii/S0007455115003689
2016
false
false
false
Netherlands
French
journal article
nilotinib
nilotinib
protein-tyrosine kinases
leukemia, myeloid, chronic-phase
cardiovascular diseases
risk factors
risk assessment
cardiovascular diseases
practice guideline
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
pyrimidines
pyrimidines

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BCR-ABL-Imatinib-Dasatinib-Nilotinib-Bosutinib-Ponatinib-Medicament-ciblant-JAK-Ruxolitinib-Anticancereux-par-voie-orale-informer-prevenir-et-gerer-leurs-effets-indesirables
2016
false
false
false
France
French
practice guideline
antineoplastic agents
administration, oral
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
information dissemination
patient education as topic
drug interactions
Dasatinib
Imatinib Mesylate
fusion proteins, bcr-abl
protein kinase inhibitors
dasatinib
imatinib
nilotinib
nilotinib
bosutinib
ponatinib
ruxolitinib
janus kinases
ponatinib
ruxolitinib
bosutinib
continuity of patient care
pregnancy
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
INCB018424
aniline compounds
nitriles
quinolines
imidazoles
pyridazines
pyrimidines
pyrazoles

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Inhibiteurs-de-la-tyrosine-kinase-BCR-ABL-Glivec-R-Sprycel-R-Tasigna-R-Bosulif-R-Iclusig-R-le-depistage-du-virus-de-l-hepatite-B-VHB-doit-etre-realise-avant-initiation-du-traitement-en-raison-du-risque-de-reactivation-de-l-hepatite-B-Lettre-aux-professionnels-de-sante
2016
false
false
false
France
French
guidelines for drug use
mass screening
protein kinase inhibitors
Hepatitis B reactivation
hepatitis B
fusion proteins, bcr-abl
protein kinase inhibitors
continuity of patient care
hepatitis b virus
Imatinib Mesylate
nilotinib
Dasatinib
bosutinib
ponatinib
hepatitis B
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
ponatinib
pyrimidines
imidazoles
pyridazines
aniline compounds
nitriles
quinolines

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BRAF-en-monotherapie-vemurafenib-dabrafenib-Medicaments-ciblant-BRAF-ou-MEK-en-association-vemurafenib-cobimetinib-dabrafenib-trametinib
2016
false
false
false
France
French
guidelines for drug use
practice guideline
patients guideline
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
administration, oral
drug interactions
vemurafenib
vemurafenib
antineoplastic combined chemotherapy protocols
vemurafenib
dabrafenib
dabrafenib
dabrafenib
BRAF protein, human
Metastatic Melanoma
melanoma
melanoma
neoplasm metastasis
BRAF Gene Mutation
continuity of patient care
drug monitoring
interdisciplinary communication
protein kinase inhibitors
vemurafenib
dabrafenib
pregnancy
vemurafenib
vemurafenib
vemurafenib
imidazoles
oximes
imidazoles
oximes
proto-oncogene proteins b-raf
imidazoles
oximes
indoles
sulfonamides
indoles
sulfonamides
indoles
sulfonamides

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-inhibiteurs-de-la-voie-Hedgehog-vismodegib
2016
false
false
false
France
French
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patients guideline
practice guideline
vismodegib
vismodegib
vismodegib
vismodegib
antineoplastic agents
antineoplastic agents
antineoplastic agents
carcinoma, basal cell
pregnancy
drug interactions
interdisciplinary communication
Hedgehog Signaling Pathway
signal transduction
hedgehog proteins
continuity of patient care
drug monitoring
HhAntag691
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines
anilides
pyridines

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-EGFR-erlotinib-gefitinib-afatinib
2016
false
false
false
France
French
guidelines for drug use
patients guideline
practice guideline
antineoplastic agents
antineoplastic agents
antineoplastic agents
administration, oral
Erlotinib Hydrochloride
Erlotinib Hydrochloride
Erlotinib Hydrochloride
erlotinib
protein kinase inhibitors
protein kinase inhibitors
protein kinase inhibitors
receptor, epidermal growth factor
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
drug interactions
pregnancy
carcinoma, non-small-cell lung
gefitinib
gefitinib
interdisciplinary communication
gefitinib
afatinib
afatinib
afatinib
afatinib
gefitinib
afatinib
afatinib
afatinib
quinazolines
quinazolines
quinazolines

---
https://medicalforum.ch/fr/article/doi/fms.2016.02616/
2016
false
false
false
Switzerland
French
review of literature
administration, oral
SGLT2 Inhibitor
Sodium-Glucose transporter 2
diabetes mellitus, type 2
glycosuria
urinary tract infections
risk factors
candidiasis, vulvovaginal
balanitis
candidal balanitis
hypoglycemic agents
candidiasis, vulvovaginal
balanitis
urinary tract infections
SGLT2 Inhibitor

---
http://www.sciencedirect.com/science/article/pii/S0007455116000606
10.1016/j.bulcan.2016.02.001
2016
false
false
false
France
French
pregnancy
Tyrosine Kinase Inhibitor
protein kinase inhibitors
protein-tyrosine kinases
journal article
risk assessment
review of literature
fetus
abortion, spontaneous
abnormalities, drug-induced
antineoplastic agents

---
SUNVEPRA - Summary Basis of Decision (SBD)
Asunaprevir, 100 mg , capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00297
2016
false
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
asunaprevir
asunaprevir
asunaprevir
NS3 protein, hepatitis C virus
risk assessment
drug evaluation
drug approval
canada
adult
hepatitis C, chronic
drug therapy, combination
Hepatitis C virus genotype 4 (organism)
Hepatitis C virus genotype 1 (organism)
Cirrhosis of liver due to chronic hepatits C (disorder)
antiviral agents
antiviral agents
protease inhibitors
protease inhibitors
treatment outcome
isoquinolines
sulfonamides
isoquinolines
sulfonamides
viral nonstructural proteins

---
Summary Safety Review - Bcr-Abl Tyrosine Kinase Inhibitors - Assessing the Potential Harm to the Fetus
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tki-ikt-fra.php
2016
false
false
false
Canada
French
English
pregnancy
fusion proteins, bcr-abl
protein kinase inhibitors
protein-tyrosine kinases
drug evaluation
risk assessment
fetus
contraception
abnormalities, drug-induced
Tyrosine Kinase Inhibitor
abortion, spontaneous
hematologic diseases
antineoplastic agents
administration, oral
pharmacovigilance

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1083/853
2016
false
false
false
Canada
French
critical appraisal or critical reading
comparative effectiveness research
angiotensin-converting enzyme inhibitors
enalapril
enzyme inhibitors
angiotensin receptor antagonists
LCZ 696
LCZ 696
enalapril
heart failure
hospitalization
multicenter studies as topic
double-blind method
valsartan and sacubitril
neprilysin
heart failure
enalapril
evaluation studies as topic
aminobutyrates
tetrazoles
aminobutyrates
tetrazoles

---
BCR-ABL Tyrosine Kinase Inhibitors [GLEEVEC (imatinib mesylate), TASIGNA (nilotinib), BOSULIF (bosutinib), SPRYCEL (dasatinib), ICLUSIG (ponatinib hydrochloride)] - Risk of Hepatitis B Reactivation
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
fusion proteins, bcr-abl
protein kinase inhibitors
Imatinib Mesylate
risk
hepatitis b virus
imatinib
nilotinib
nilotinib
bosutinib
bosutinib
Dasatinib
dasatinib
ponatinib hydrochloride
ponatinib
Tyrosine Kinase Inhibitor
Hepatitis B reactivation
guidelines for drug use
continuity of patient care
mass screening
hepatitis B
hepatitis B
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
ponatinib
pyrimidines
imidazoles
pyridazines
aniline compounds
nitriles
quinolines

---
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58404a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
Sodium-Glucose transporter 2
SGLT2 Inhibitor
Canagliflozin
hypoglycemic agents
dapagliflozin
metformin and dapagliflozin
drug combinations
metformin
empagliflozin
diabetic ketoacidosis
guidelines for drug use
diabetes mellitus, type 2
risk factors
dapagliflozin
canagliflozin
empagliflozin
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
glucosides
benzhydryl compounds

---
http://www.cochrane.org/fr/CD004179/les-anticoagulants-pris-sur-des-durees-prolongees-pour-prevenir-la-thrombose-veineuse-profonde-ou
2016
false
false
false
France
French
review of literature
french abstract
treatment outcome
venous thrombosis
pulmonary embolism
anticoagulants
drug administration schedule
arthroplasty, replacement, hip
hip prosthesis
arthroplasty, replacement, knee
knee prosthesis
postoperative complications
heparin, low-molecular-weight
vitamin K
anticoagulants
femoral neck fractures
chemoprevention

---
Summary Basis of Decision (SBD) for Bridion
Sugammadex sodium, 100 mg/mL, solution, intravenous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00283
2016
false
false
false
Canada
French
English
summary of product characteristics
sugammadex
sugammadex
Sugammadex sodium
Sugammadex sodium
injections, intravenous
sugammadex
rocuronium
vecuronium bromide
neuromuscular nondepolarizing agents
anesthesia recovery period
neuromuscular blockade reversal
adult
risk assessment
neuromuscular blockade
gamma-cyclodextrins
gamma-cyclodextrins
androstanols

---
http://www.sfetd-douleur.org/sites/default/files/u3349/DossierdumoisSFETD/2016/antagonistes_nmda_version_finale.pdf
2016
false
false
false
France
French
receptors, n-methyl-d-aspartate
drug information
treatment outcome
ketamine
neuralgia
Neuropathic Pain
chronic pain
memantine
dextromethorphan
fibromyalgia
risk assessment
analgesics

---
https://medicalforum.ch/fr/article/doi/fms.2016.02684/
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
practice guidelines as topic
glucagon-like peptide 1
GLP-1 Mimetics
GLP-1 Mimetics
dipeptidyl-peptidase iv inhibitors
cardiovascular diseases
obesity
Sodium-Glucose transporter 2
SGLT2 Inhibitor
SGLT2 Inhibitor
insulins
risk factors
weight loss
hypoglycemia
insulins
hypoglycemic agents

---
http://www.minerva-ebm.be/FR/Article/2056
2016
false
false
false
Belgium
French
french abstract
atrial fibrillation
heparin, low-molecular-weight
anticoagulants
preoperative care
thromboembolism
hemorrhage
vitamin K
Elective Surgical Procedures

---
https://medicalforum.ch/fr/article/doi/fms.2016.02723/
2016
false
false
false
Switzerland
French
journal article
macular degeneration
aged
aged, 80 and over
macular degeneration
macular degeneration
vascular endothelial growth factors
Drug-Related side effects and adverse reactions

---
http://pharmacomedicale.org/medicaments/par-specialites/item/stimulants-de-la-cognition-les-points-essentiels
2015
false
false
false
France
French
drug information
cognition disorders
excitatory amino acid antagonists
receptors, n-methyl-d-aspartate
cholinesterase inhibitors
cognition, nos
central nervous system stimulants
cognition
stimulator, nos
essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/anti-tnf-alpha
2015
false
false
false
France
French
drug information
tumor necrosis factor-alpha
tumor necrosis factor alpha (tnf-alpha) inhibitors
Anti-tumor necrosis factor alpha agent (substance)
tumor necrosis factor-alpha
tumor necrosis factor alpha

---
http://www.ansm.sante.fr/Dossiers-thematiques/Securite-du-medicament-a-l-hopital/Erreur-lors-de-la-prise-en-charge-des-patients-atteints-de-fibrillation-auriculaire-et-traites-avec-des-medicaments-anticoagulants-oraux/(offset)/1
2015
false
France
French
phenindione
anticoagulants
administration, oral
vitamin K
atrial fibrillation
medication errors
france
hemorrhage
fluindione
vitamin k antagonists
medication errors
pharmacovigilance note
guidelines for drug use

---
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=482
http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspa20150303_grippesaisrecoutilantiviraux.pdf
2015
false
false
false
France
French
influenza, human
antiviral agents
public health guidelines
neuraminidase
child
adult
aged
influenza, human

---
http://ansm.sante.fr/Dossiers/Anti-vitamine-K-AVK/
2015
false
false
false
France
French
antivitamins K
antivitamins K
continuity of patient care
drug monitoring
vitamin K
administration, oral
anticoagulants
anticoagulants
hemorrhage
patients guideline
guidelines for drug use
patient education handout
package leaflet
examination questions
vitamin k antagonists
hemorrhage
antivitamins K
Anticoagulant-induced bleeding (disorder)
indenes
4-hydroxycoumarins
indenes
4-hydroxycoumarins
indenes
4-hydroxycoumarins

---
http://www.minerva-ebm.be/fr/article/1088
2015
false
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
diabetes mellitus, type 2
Sodium-Glucose transporter 2
treatment outcome
hypoglycemic agents

---
http://www.revmed.ch/rms/2015/RMS-N-477/Analogues-du-GLP-1-versus-inhibiteurs-du-SGLT-2-pour-les-diabetiques-de-type-2-obeses
2015
false
false
false
Switzerland
French
diabetes mellitus, type 2
obesity
comparative effectiveness research
treatment outcome
incretins
hypoglycemic agents
Liraglutide
glucagon-like peptide 1
exenatide
Canagliflozin
Sodium-Glucose transporter 2
SGLT2 Inhibitor
dapagliflozin
empagliflozin
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol
other blood glucose lowering drugs, excl. insulins
GLP-1 Mimetics
journal article
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
glucosides
benzhydryl compounds
peptides
venoms
sorbitol
sorbitol

---
Information Update - Forxiga, Invokana: Health Canada begins safety review of diabetes drugs known as SGLT2 inhibitors and risk of ketoacidosis
http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/forxiga-invokana-fra.php
2015
false
false
false
Canada
French
English
SGLT2 Inhibitor
Sodium-Glucose transporter 2
diabetic ketoacidosis
risk
administration, oral
diabetes mellitus, type 2
dapagliflozin
hypoglycemic agents
pharmacovigilance note
patient education handout
Canagliflozin
dapagliflozin
canagliflozin
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
benzhydryl compounds

---
http://devsante.org/base-documentaire/traitements-vaccins/interactions-medicamenteuses-avec-les-anticoagulants
2015
false
false
false
France
French
anticoagulants
drug interactions
drug information
thromboembolism
continuity of patient care
anticoagulants
administration, oral
hemorrhage
injections, subcutaneous
vitamin k antagonists
heparin
antivitamins K
aspirin
heparin group
acetylsalicylic acid
platelet aggregation inhibitors
journal article
antivitamins K
anticoagulotherapy
indenes
vitamin K
vitamin K
4-hydroxycoumarins
indenes
4-hydroxycoumarins

---
http://www.societechirorale.com/documents/Recommandations/recommandations_festion_peri_operatoire_2015_court.pdf
http://www.societechirorale.com/documents/Recommandations/recommandations_festion_peri_operatoire_2015_argumentaire.doc
http://www.mbcb-journal.org/articles/mbcb/abs/2015/04/contents/contents.html
http://dx.doi.org/10.1051/mbcb/2015036
2015
false
true
false
France
French
fibrinolytic agents
practice guideline
oral surgical procedures
risk assessment
postoperative hemorrhage
hemostatics
vitamin K
anticoagulants
Identifying Risk For Haemorrhaging
Risk For Haemorrhaging Process
heparin
platelet aggregation inhibitors
antivitamins K
antivitamins K
journal article
therapy cessation
anticoagulotherapy
indenes
4-hydroxycoumarins
indenes
4-hydroxycoumarins

---
http://www.e-cancer.fr/content/download/126025/1524695/file/Médicaments%20ciblant%20BCR-ABL.pdf
2015
false
false
false
France
French
practice guideline
guidelines for drug use
administration, oral
antineoplastic agents
Drug-Related side effects and adverse reactions
imatinib
dasatinib
nilotinib
nilotinib
bosutinib
bosutinib
ponatinib
ponatinib
protein kinase inhibitors
ruxolitinib
ruxolitinib
janus kinases
information dissemination
continuity of patient care
hospital-physician relations
hospital-patient relations
physician-patient relations
drug interactions
pregnancy
protein-tyrosine kinases
Tyrosine Kinase Inhibitor
Dasatinib
Imatinib Mesylate
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
INCB018424
pyrazoles
aniline compounds
nitriles
quinolines
imidazoles
pyridazines

---
http://www.jle.com/fr/revues/hpg/e-docs/les_manifestations_cutanees_des_anti_tnf_alpha_305568/article.phtml
2015
false
false
false
France
French
journal article
tumor necrosis factor-alpha
tumor necrosis factor-alpha
case reports
image
skin diseases
algorithms
examination questions
dermatitis psoriasiform
Anti-tumor necrosis factor alpha agent (substance)

---
http://ansm.sante.fr/S-informer/Travaux-de-l-Agence-Europeenne-des-Medicaments-EMA-Comite-pour-l-evaluation-des-risques-en-matiere-de-pharmacovigilance-PRAC/Demarrage-par-le-PRAC-de-l-evaluation-de-l-impact-du-risque-d-acidocetose-diabetique-sur-le-rapport-benefice-risque-des-SGLT2-Point-d-information
2015
false
false
false
France
French
drug evaluation
risk assessment
drug information
diabetic ketoacidosis
administration, oral
adult
diabetes mellitus, type 2
SGLT2 Inhibitor
Sodium-Glucose transporter 2
hypoglycemic agents
dapagliflozin
drug combinations
metformin
empagliflozin
metformin and dapagliflozin
metformin and canagliflozin
metformin and empagliflozin
Canagliflozin
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
benzhydryl compounds

---
http://www.has-sante.fr/portail/jcms/c_1751169/fr/benlysta
http://www.has-sante.fr/portail/jcms/c_1234522/benlysta
2014
false
France
French
evaluation of the transparency committee
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
guidelines for drug use
secondary prevention
corticosteroid therapy
belimumab
belimumab
antibodies, monoclonal
antibodies, monoclonal
belimumab
immunosuppressive agents
immunosuppressive agents
TNFSF13B protein, human
b-cell activating factor
lupus erythematosus, systemic
treatment outcome
drug therapy, combination
adult
infusions, intravenous
randomized controlled trials as topic
risk management
clinical trials, phase iii as topic
antibodies, antinuclear

---
http://ageps.aphp.fr/wp-content/blogs.dir/68/files/2015/05/Recommandations-antithrombotiques-COMEDIMS-APHP-AGEPS-2014-Oct.pdf
2014
false
false
true
France
French
guidelines for drug use
platelet aggregation inhibitors
anticoagulants
venous thromboembolism
deep vein thrombosis
antivitamins K
heparin
administration, oral
injections, subcutaneous
fondaparinux
bivalirudin
apixaban
danaparoid
venous thrombosis
venous thrombosis
postoperative complications
atrial fibrillation
heart valve diseases
heart valve prosthesis implantation
acute coronary syndrome
myocardial ischemia
algorithms
adult
aged
pregnancy
contraceptives, oral
venous thromboembolism
continuity of patient care
antiphospholipid syndrome
renal insufficiency
obesity
cachexia
hemorrhage
anticoagulants
vitamin K
antithrombins
antithrombotic agents
Factor Xa Inhibitors
drug monitoring
hematologic tests
international normalized ratio
anticoagulotherapy
Rivaroxaban
Dabigatran
venous thrombosis
danaproid
chondroitin sulfates
dermatan sulfate
heparitin sulfate
indenes
4-hydroxycoumarins
polysaccharides
hirudins
peptide fragments
recombinant proteins
pyrazoles
pyridones

---
http://www.has-sante.fr/portail/jcms/c_1741768/fr/guide-parcours-de-soins-fibrillation-atriale
http://www.has-sante.fr/portail/jcms/c_1741766/fr/guide-parcours-de-soins-fibrillation-atriale
2014
true
France
French
atrial fibrillation
practice guideline
disease management
general practice
atrial fibrillation
atrial fibrillation
anticoagulants
algorithms
continuity of patient care
vitamin K
hemorrhage
pregnancy
anticoagulotherapy
general practitioners

---
http://www.cochrane.org/fr/CD005208
2014
false
false
false
France
stroke
platelet glycoprotein GPIIb-IIIa complex
cerebral hemorrhage
treatment outcome
abciximab
aspirin
acute disease
platelet aggregation inhibitors
platelet aggregation inhibitors
meta-analysis
french abstract
antibodies, monoclonal
immunoglobulin fab fragments

---
http://www.cochrane.org/fr/CD004452
2014
false
false
false
France
barusiban
atosiban
tocolytic agents
barusiban
atosiban
tocolytic agents
treatment outcome
pregnancy
meta-analysis
french abstract
obstetric labor, premature
receptors, oxytocin
oligopeptides
vasotocin
vasotocin
oligopeptides
vasotocin

---
http://www.cochrane.org/fr/CD008139
2014
false
true
false
France
neuraminidase
treatment outcome
review of literature
french abstract
cystic fibrosis
neuraminidase
influenza, human

---
http://www.cochrane.org/fr/CD001367
2014
false
false
false
France
anticoagulants
treatment outcome
venous thromboembolism
secondary prevention
recurrence
anticoagulotherapy
meta-analysis
french abstract
vitamin K
venous thromboembolism
time factors

---
http://www.cochrane.org/fr/CD006468
2014
false
false
false
France
thrombosis
treatment outcome
neoplasms
heparin
vitamin K
anticoagulotherapy
meta-analysis
french abstract
central venous catheters
anticoagulants

---
http://www.cochrane.org/fr/CD007325
2014
false
false
false
France
treatment outcome
meta-analysis
french abstract
macular edema
retinal vein occlusion
endothelial growth factors

---
http://www.ameli.fr/professionnels-de-sante/medecins/exercer-au-quotidien/aide-a-la-pratique-memos/les-memos-medico-economiques/traitements-par-anti-tnf-alpha-dans-la-pr-et-la-sa.php
2014
false
false
false
France
scientific and technical information
arthritis, rheumatoid
spondylitis, ankylosing
drug therapy
france
adult
tumor necrosis factor-alpha

---
http://www.sciencedirect.com/science/article/pii/S1169833013002858
http://www.has-sante.fr/portail/jcms/c_1701342/fr/label-de-la-has-anti-tnf-conseils-dutilisation-et-recommandations-de-bonne-pratique?xtmc=&xtcr=6
2014
false
true
true
France
French
journal article
practice guideline
spondylarthropathies
spondylarthropathies
spondylarthropathies
spondylarthropathies
anti-inflammatory agents, non-steroidal
tumor necrosis factors
spondylarthropathies

---
http://www.cochrane.org/fr/CD009893/les-inhibiteurs-directs-de-la-thrombine-par-rapport-aux-antagonistes-de-la-vitamine-k-chez-les-patients-souffrant-de-fibrillation-auriculaire-pour-prevenir-laccident-vasculaire-cerebral-avc
2014
false
false
false
France
French
meta-analysis
atrial fibrillation
vitamin K
stroke
treatment outcome
french abstract
antithrombins
antithrombins
anticoagulants
anticoagulotherapy

---
http://www.has-sante.fr/portail/jcms/c_1252051/fr/prevention-vasculaire-apres-un-infarctus-cerebral-ou-un-accident-ischemique-transitoire
http://www.has-sante.fr/portail/jcms/c_1764101/fr/prevention-vasculaire-apres-un-ic-ou-un-ait-argumentaire
2014
false
true
true
France
French
practice guideline
cerebral infarction
ischemic attack, transient
stroke
myocardial infarction
adult
hypertension
antihypertensive agents
dyslipidemias
hydroxymethylglutaryl-coa reductase inhibitors
diabetes mellitus
smoking
alcohol drinking
obesity
hyperhomocysteinemia
atrial fibrillation
vitamin K
anticoagulants
foramen ovale, patent
fibrinolytic agents
heart valve prosthesis
heart valve diseases
platelet aggregation inhibitors
carotid stenosis
endarterectomy, carotid
vertebral artery dissection
anticoagulotherapy

---
http://www.academie-medecine.fr/articles-du-bulletin/publication/?idpublication=100330
http://www.academie-medecine.fr/wp-content/uploads/2014/06/aod2805.pdf
2014
false
false
false
France
French
anticoagulants
administration, oral
technical report
anticoagulants
drug interactions
thromboembolism
anticoagulants
pyridines
apixaban
pyrazoles
pyridones
atrial fibrillation
antithrombins
thiazoles
edoxaban
acute coronary syndrome
anticoagulants
vitamin K
orthopedic procedures
anticoagulotherapy
Dabigatran
Dabigatran
Rivaroxaban

---
https://medicalforum.ch/fr/article/doi/fms.2014.02112/
2014
false
false
false
Switzerland
French
journal article
neuroendocrine tumors
receptors, somatostatin
radiopharmaceuticals

---
http://www.amub.be/revue-medicale-bruxelles/article/les-nouveaux-anti-diabetiques-oraux-1032
http://www.amub.be/revue-medicale-bruxelles/download/1032
2014
false
false
false
false
Belgium
French
journal article
comparative study
diabetes mellitus, type 2
incretins
hypoglycemic agents
administration, oral
incretins
gastric inhibitory polypeptide
glucagon-like peptide 1
dipeptidyl-peptidase iv inhibitors
dipeptidyl peptidase (dpp-4) inhibitors
other blood glucose lowering drugs, excl. insulins
incretins
hypoglycemic agents
hypoglycemic agents
SLC5A2 protein, human
risk factors
drug therapy, combination
treatment outcome
Glucagon-Like Peptide-1 Receptor
Sodium-Glucose transporter 2

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Pourquoi-quand-et-comment-doser-les-nouveaux-anticoagulants-oraux
2014
false
false
false
Switzerland
French
journal article
thromboembolism
continuity of patient care
drug monitoring
anticoagulants
administration, oral
rivaroxaban
apixaban
dabigatran etexilate
apixaban
risk factors
blood coagulation tests
kidney failure, chronic
factor xa
antithrombins
Factor Xa Inhibitors
Rivaroxaban
Dabigatran
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Gestion-peri-interventionnelle-des-nouveaux-anticoagulants-oraux-directs
2014
false
false
false
Switzerland
French
journal article
administration, oral
anticoagulants
factor xa
perioperative care
postoperative hemorrhage
blood loss, surgical
anticoagulants
apixaban
antithrombins
antithrombins
Factor Xa Inhibitors
therapy cessation
anticoagulotherapy
Dabigatran
Rivaroxaban
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Nouveaux-anticoagulants-oraux-donnees-pharmacologiques-a-connaitre-pour-la-pratique-clinique
2014
false
false
false
Switzerland
French
journal article
anticoagulants
administration, oral
antithrombins
factor xa
apixaban
thromboembolism
thromboembolism
drug interactions
renal insufficiency
hepatic insufficiency
aged
obesity
anticoagulants
antithrombins
Factor Xa Inhibitors
anticoagulotherapy
Rivaroxaban
Dabigatran
pyrazoles
pyridones

---
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v24n1-fra.php#article1
2014
Canada
French
English
pharmacovigilance note
receptors, vascular endothelial growth factor
thrombotic microangiopathies
thrombotic microangiopathies
signs and symptoms
sunitinib
antineoplastic agents
angiogenesis inhibitors
sunitinib
sorafenib
sorafenib
pazopanib
pazopanib
vandetanib
vandetanib
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
axitinib
axitinib
regorafenib
journal article
regorafenib
piperidines
quinazolines
benzenesulfonates
pyridines
indoles
pyrroles
imidazoles
indazoles
pyrimidines
sulfonamides
phenylurea compounds
niacinamide

---
http://www.ansm.sante.fr/var/ansm_site/storage/original/application/027295b45004ada6fe20b8d5b608e7d8.pdf
2013
false
France
French
antivitamins K
anticoagulotherapy
antivitamins K
antivitamins K
vitamin k antagonists
drug monitoring
international normalized ratio
anticoagulants
vitamin K
anticoagulants
forms
patient education handout
drug information
indenes
4-hydroxycoumarins

---
http://www.cochrane.org/fr/CD008980
2013
France
French
review of literature
french abstract
thromboembolism
vitamin K
atrial fibrillation
antithrombin III
antifibrinolytic agents
treatment outcome

---
http://www.sfdermato.org/media/pdf/recommandation/traitements-anti-tnf-recos-64222d1c6f9c32cb666ec9ac141d2349.pdf
2013
true
France
French
continuity of patient care
autoimmune diseases
risk assessment
neoplasms
mass screening
neoplasms
hematologic diseases
herpesviridae infections
herpesvirus 3, human
herpes simplex
malaria
histoplasmosis
legionellosis
hepatitis B
hepatitis C
vaccines
vaccination
pregnancy
surgical procedures, operative
aged
tumor necrosis factor-alpha
guidelines for drug use
journal article
antibodies, monoclonal
antibodies, monoclonal
antirheumatic agents
antirheumatic agents
tumor necrosis factor alpha (tnf-alpha) inhibitors

---
http://rms.medhyg.ch/numero-368-page-12.htm
2013
Switzerland
French
journal article
Anti-tumor necrosis factor alpha drug (product)
Anti-tumor necrosis factor alpha agent (substance)
tumor necrosis factors
tumor necrosis factors

---
http://www.omeditbretagne.fr/lrportal/documents/138946/147512/OMIT_AFINITOR+V1_7pro.pdf/16bec256-5a62-421d-977e-98a8c312be41
2013
false
false
false
France
French
guidelines for drug use
TOR Serine-Threonine kinases
everolimus
protein kinase inhibitors
protein kinase inhibitors
antineoplastic agents
antineoplastic agents
administration, oral
drug interactions
continuity of patient care
Drug-Related side effects and adverse reactions
carcinoma, renal cell
breast neoplasms
Advanced breast cancer
Advanced Malignant Neoplasm
neuroendocrine tumors
pancreatic neoplasms
Pancreatic Neuroendocrine Tumor
Everolimus
Everolimus
everolimus

---
https://www.revmed.ch/RMS/2013/RMS-375/Calcifications-vasculaires-et-deficit-en-vitamine-K-un-facteur-de-risque-modifiable-dans-l-insuffisance-renale-chronique
2013
Switzerland
French
vascular calcification
renal insufficiency, chronic
journal article
vitamin K 2
vitamin K
anticoagulants
vitamin k deficiency

---
http://www.cochrane.org/fr/CD005938
2013
false
true
false
France
obstetric labor, premature
obstetric labor, premature
oxytocin
treatment outcome
review of literature
french abstract
oxytocin

---
http://www.cochrane.org/fr/CD002130
2013
false
true
false
France
platelet membrane glycoproteins
acute coronary syndrome
treatment outcome
review of literature
french abstract
percutaneous coronary intervention

---
https://www.inspq.qc.ca/publications/1713
http://www.inspq.qc.ca/pdf/publications/1713_RapSurvLaboEnterobacCarbapIsoleesQc.pdf
2013
false
true
false
Canada
drug resistance, bacterial
biosurveillance
enterobacteriaceae
technical report
quebec
enterobacteriaceae
carbapenems

---
http://theseimg.fr/1/node/147
2013
France
French
dissertations, academic
antivitamins K
vitamin K
anticoagulants
hemorrhage
outpatients
patient education as topic
risk assessment
antivitamins K
anticoagulotherapy
general practice
general practitioners
indenes
4-hydroxycoumarins

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000885/human_med_000680.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124&jsenabled=true
2012
Great Britain (UK)
French
English
syndication feed
gamma-cyclodextrins
gamma-cyclodextrins
antidotes
drug approval
drug labeling
treatment outcome
injections, intravenous
adult
child
adolescent
vecuronium bromide
neuromuscular nondepolarizing agents
androstanols
anesthesia recovery period
respiratory muscles
neuromuscular blockade
aged
monitoring, physiologic
drug interactions
breast feeding
drug evaluation, preclinical
antidotes
pregnancy
drug incompatibility
drug storage
drug compounding
sugammadex
sugammadex
rocuronium
sugammadex
androstanols
gamma-cyclodextrins
package leaflet
drug evaluation
summary of product characteristics

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/881
2012
false
false
false
Canada
drug eruptions
journal article
receptor, epidermal growth factor
patient care management
growth factors

---
http://www.has-sante.fr/portail/jcms/c_1191381/tamiflu-oseltamivir-antiviral-inhibiteur-de-la-neuraminidase
http://www.has-sante.fr/portail/jcms/c_1191332/tamiflu-02112011-synthese-ct9677
http://www.has-sante.fr/portail/jcms/c_1147021/tamiflu-02-11-2011-avis-ct-9677
2012
false
France
French
Neuraminidase inhibitor (substance)
oseltamivir
antiviral agents
enzyme inhibitors
neuraminidase
administration, oral
influenza, human
adult
child
oseltamivir
treatment outcome
infant
pandemics
influenza, human
Post-Exposure prophylaxis
follow-up studies
insurance, health, reimbursement
evaluation of the transparency committee
guidelines for drug use

---
http://www.rmlg.ulg.ac.be/aboel.php?num_id=2276&langue=FR
2012
Belgium
French
crohn disease
tumor necrosis factors
journal article

---
http://www.has-sante.fr/portail/jcms/c_1294163/roactemra-tocilizumab-inhibiteur-de-linterleukine-6
http://www.has-sante.fr/portail/jcms/c_1294071/roactemra-aji-synthese-09052012
http://www.has-sante.fr/portail/jcms/c_1250744/roactemra-09052012-avis-ct-11877
2012
false
France
French
evaluation of the transparency committee
tocilizumab
receptors, interleukin-6
tocilizumab
tocilizumab
arthritis, juvenile
child
treatment outcome
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
infusions, intravenous
drug therapy, combination
continuity of patient care
clinical trials as topic
drug monitoring
risk management

---
http://www.inspq.qc.ca/pdf/publications/1566_MedSystHormonalCanicules.pdf
2012
false
Canada
French
corticosteroid therapy
Ezetimibe
extreme heat
risk factors
administration, oral
hypoglycemic agents
quebec
Drug-Related side effects and adverse reactions
hypolipidemic agents
population characteristics
bibliography as topic
thyroid hormones
renal insufficiency
glyburide
iodine radioisotopes
zoledronic acid
mineralocorticoids
bromocriptine
insulin
dehydration
alpha-Glucosidases
alpha glucosidase inhibitors
guidelines for drug use
practice guideline
biguanides
biguanides
dipeptidyl peptidase (dpp-4) inhibitors
dipeptidyl-peptidase iv inhibitors
glucagon-like peptide 1
water-electrolyte imbalance
niacin
nicotinic acid
bile acid sequestrants
fibrates
fibric acids
hmg coa reductase inhibitors
hydroxymethylglutaryl-coa reductase inhibitors
ezetimibe
anion exchange resins
reports and studies
thyroid hormones
diphosphonates
imidazoles

---
http://www.cochrane.org/fr/CD007687
2012
France
French
meta-analysis
mifepristone
leiomyoma
treatment outcome
receptors, progesterone
french abstract

---
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=297
http://www.hcsp.fr/explore.cgi/hcspr20121109_antivirauxextrahospgrippe.pdf
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=298
2012
France
French
influenza, human
public health guidelines
guideline
neuraminidase
neuraminidase
neuraminidase inhibitors
treatment outcome
antiviral agents

---
http://www.cochrane.org/fr/CD001342
2012
France
French
anticoagulotherapy
meta-analysis
vitamin K
ischemic attack, transient
stroke
treatment outcome
french abstract
anticoagulants
platelet aggregation inhibitors

---
http://www.has-sante.fr/portail/jcms/c_1355322/zelboraf-vemurafenib-inhibiteur-de-la-proteine-kinase-braf
http://www.has-sante.fr/portail/jcms/c_1355321/zelboraf-synthese-ct12121
2012
France
French
melanoma
evaluation of the transparency committee
guidelines for drug use
vemurafenib
vemurafenib
indoles
sulfonamides
proto-oncogene proteins b-raf

---
http://www.cochrane.org/fr/CD002122
2012
France
French
review of literature
endometriosis
pain management
treatment outcome
progesterone congeners
progestins
pelvic pain
french abstract

---
http://ansm.sante.fr/var/ansm_site/storage/original/application/6d550a9311848623e57d311cc0ebacbe.pdf
2012
France
French
secondary prevention
antivitamins K
anticoagulotherapy
antivitamins K
anticoagulants
vitamin K
guidelines for drug use
risk assessment
international normalized ratio
continuity of patient care
patient education as topic
administration, oral
acenocoumarol
fluindione
warfarin
Warfarin Sodium
fluindione
warfarin
acenocoumarol
thromboembolism
venous thrombosis
pulmonary embolism
heart diseases
heart diseases
myocardial infarction
heart valve prosthesis
drug monitoring
drug interactions
pregnancy
breast feeding
phenindione
indenes
4-hydroxycoumarins

---
http://www.cochrane.org/fr/CD002744
2012
false
France
French
Neuraminidase inhibitor (substance)
meta-analysis
influenza, human
child
influenza, human
antiviral agents
neuraminidase
enzyme inhibitors
infant
french abstract

---
http://campus.cerimes.fr/cardiologie-et-maladies-vasculaires/enseignement/cardio_182/site/html/
http://campus.cerimes.fr/cardiologie-et-maladies-vasculaires/enseignement/cardio_182/site/html/cours.pdf
http://campus.cerimes.fr/cardiologie-et-maladies-vasculaires/enseignement/cardio_182/site/html/1.html
2012
true
France
French
anticoagulotherapy
educational course
French pre-residency program examination
anticoagulants
Drug-Related side effects and adverse reactions
heparin
vitamin K
heparin

---
https://www.revmed.ch/RMS/2012/RMS-351/Y-a-t-il-encore-une-place-pour-la-double-inhibition-du-systeme-renine-angiotensine-en-2012
2012
Switzerland
French
renin-angiotensin system
journal article
renin-angiotensin system inhibition
angiotensin-converting enzyme inhibitors
angiotensin II type 1 receptor blockers
renin
aliskiren
amides
fumarates

---
http://www.cochrane.org/fr/CD003986
2012
France
French
review of literature
craniocerebral trauma
treatment outcome
excitatory amino acids
excitatory amino acid antagonists
french abstract

---
http://www.rmlg.ulg.ac.be/aboel.php?num_id=2275&langue=FR
2012
Belgium
French
tumor necrosis factors
tumor necrosis factors
journal article
psoriasis
image
eczema
skin diseases

---
http://www.cochrane.org/fr/CD007419
2012
false
France
French
french abstract
meta-analysis
macular edema
diabetic retinopathy
angiogenesis inhibitors
vascular endothelial growth factors
treatment outcome
Diabetic macular oedema
diabetes complications

---
https://www.fmoq.org/formation/repertoire-de-guides-cliniques-et-de-lignes-directrices/anticoagulotherapie/
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_outil_choix_anticoagulotherapie.pdf
2012
false
true
false
Canada
factor xa
anticoagulants
anticoagulants
anticoagulants
anticoagulants
Rivaroxaban
technical report
atrial fibrillation
adult

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002015/human_med_001466.jsp&mid=WC0b01ac058001d124&murl=menus/medicines/medicines.jsp
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500106483
2012
Great Britain (UK)
English
French
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
syndication feed
belimumab
belimumab
drug approval
treatment outcome
infusions, intravenous
adult
lupus erythematosus, systemic
antibodies, monoclonal
antibodies, monoclonal
belimumab
b-cell activating factor
TNFSF13B protein, human

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-Anti-EGFR_et_colorectal_(2011-08-19).pdf
2011
false
false
Canada
French
colorectal neoplasms
treatment outcome
neoplasm metastasis
receptor, epidermal growth factor
receptor, epidermal growth factor
practice guideline

---
http://www.has-sante.fr/portail/jcms/c_1009982/biologie-des-anomalies-de-lhemostase-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084558/biologie-anomalie-hemostase-t1-temps-de-saignement-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084559/biologie-anomalie-hemostase-t2-thrombine-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084560/biologie-anomalie-hemostase-t3-tap-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084561/biologie-anomalie-hemostase-t4-ac-anti-f4p-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084562/biologie-anomalie-hemostase-t5-inhibiteurs-fah-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084563/biologie-anomalie-hemostase-t6-al-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084564/biologie-anomalie-hemostase-t7-mutations-fii-et-fv-rapport-d-evaluation
2011
true
France
French
health technology assessment
hemostatic disorders
bleeding time
thrombin time
platelet aggregation
platelet factor 4
factor VIII
lupus coagulation inhibitor
factor v
prothrombin
factor V leiden

---
https://www.revmed.ch/RMS/2011/RMS-277/Rhumatologie.-ANTI-TNFa-quels-risques-infectieux-Recommandations-pratiques
2011
Switzerland
French
journal article
rheumatic diseases
tumor necrosis factor-alpha
tumor necrosis factor-alpha
tumor necrosis factor-alpha
infection

---
http://unt-ori2.crihan.fr/unspf/2011_Angers_Faure_Angiotensine/co/syst_angiotensine_web.html
2011
false
true
France
renin-angiotensin system
educational course
problems and exercises
multiple choice quizz
agents acting on the renin-angiotensin system
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitors
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
pharmacology
renin
drug interactions
hypertension
heart failure
myocardial infarction
diabetic nephropathies
education, pharmacy

---
http://www.cochrane.org/fr/CD005981
2011
false
true
false
France
arthroplasty
treatment outcome
review of literature
french abstract
antithrombins
vitamin K
venous thromboembolism
heparin, low-molecular-weight

---
http://www.inspq.qc.ca/pdf/publications/1272_ResistanceAntituberculeux_2010.pdf
2011
false
true
false
Canada
drug resistance, bacterial
tuberculosis
technical report
quebec
antitubercular agents

---
http://www.rmlg.ulg.ac.be/aboel.php?num_id=2155&langue=FR
2011
false
true
false
Belgium
excitatory amino acid agents
depression
depression
depressive disorder
depressive disorder
tumor necrosis factor-alpha
journal article
excitatory amino acid agents
antidepressive agents

---
https://www.revmed.ch/RMS/2011/RMS-278/Allergo-immunologie.-1.-Nouveautes-dans-le-traitement-des-crises-aigues-d-angioedeme-hereditaire
2011
false
true
false
Switzerland
bradykinin
angioedemas, hereditary
receptors, bradykinin
icatibant
journal article
angioedemas, hereditary
bradykinin

---
http://www.cochrane.org/fr/CD007066
2011
false
true
false
France
antihypertensive agents
treatment outcome
review of literature
french abstract
hypertension
renin

---
http://www.jle.com/fr/revues/medecine/gpn/e-docs/00/04/65/DF/resume.phtml
2011
France
French
antivitamins K
anticoagulotherapy
aged
guideline adherence
journal article
atrial fibrillation
vitamin K
anticoagulants
antivitamins K
indenes
4-hydroxycoumarins

---
http://inpes.santepubliquefrance.fr/CFESBases/catalogue/detaildoc.asp?numfiche=1302
http://inpes.santepubliquefrance.fr/CFESBases/catalogue/pdf/1302.pdf
2010
false
France
French
pediatric obesity
Cancer Pain
Cancer Pain
cancer pain
patient education as topic
diabetes mellitus, type 1
diabetes mellitus, type 2
child
adolescent
obesity
adult
cardiovascular diseases
hiv infections
asthma
neoplasms
arthritis, rheumatoid
low back pain
vitamin K
acquired immunodeficiency syndrome
scientific and technical information
Childhood asthma (disorder)

---
http://www.inesss.qc.ca/fileadmin/doc/CDM/UsageOptimal/AINS-IPP/CdM-Principes-IPP.pdf
2010
Canada
French
lansoprazole
rabeprazole
2-Pyridinylmethylsulfinylbenzimidazoles
canada
proton pump inhibitors
proton pump inhibitors
dyspepsia
dyspepsia
anti-inflammatory agents, non-steroidal
aspirin
peptic ulcer
peptic ulcer
drug utilization review
gastroesophageal reflux
proton pump inhibitors
omeprazole
H(+)-K(+)-Exchanging ATPase
pantoprazole
peptic ulcer
guidelines for drug use

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/tracleer_-_ct-7227.pdf
http://www.has-sante.fr/portail/jcms/c_946222/tracleer-32-mg-bosentan-antagoniste-des-recepteurs-de-lendotheline
2010
France
French
bosentan
receptor, endothelin b
sulfonamides
hypertension, pulmonary
administration, oral
orphan drug production
bosentan
treatment outcome
skin ulcer
scleroderma, systemic
fingers
sulfonamides
evaluation of the transparency committee
guidelines for drug use

---
http://www.jle.com/fr/revues/nro/e-docs/les_inhibiteurs_du_facteur_xa_289391/article.phtml
2010
false
France
French
Factor Xa Inhibitors
Rivaroxaban
journal article
factor xa
atrial fibrillation
DERMATITIS
fibrinolytic agents
stroke
edoxaban
apixaban
pyrazoles
pyridones
pyridines
thiazoles
Direct factor Xa inhibitors

---
http://www.cochrane.org/fr/CD007929
2010
false
true
false
France
dna repair enzymes
treatment outcome
review of literature
french abstract
ovarian neoplasms

---
http://www.cochrane.org/fr/CD008088
2010
France
French
Cancer Pain
review of literature
endometriosis
pelvic pain
treatment outcome
tumor necrosis factor-alpha
anti-inflammatory agents
french abstract

---
http://www.cochrane.org/fr/CD001867
2010
France
French
meta-analysis
alcohol-related disorders
narcotic antagonists
treatment outcome
naltrexone
french abstract

---
http://www.snfge.org/download/file/fid/68
2010
France
French
inflammatory bowel diseases
tumor necrosis factors
checklist
scientific and technical information

---
http://www.revmed.ch/rms/2010/RMS-N-267/Y-a-t-il-une-place-aujourd-hui-pour-les-inhibiteurs-directs-de-la-renine
2010
false
true
false
Switzerland
hypertension
aliskiren
antihypertensive agents
antihypertensive agents
antihypertensive agents
antihypertensive agents
heart failure
diabetic nephropathies
Renin inhibitor (substance)
journal article
renin
amides
fumarates

---
https://www.revmed.ch/RMS/2010/RMS-235/Introduction-de-l-acenocoumarol-a-l-aide-d-un-algorithme-de-prescription
2010
false
Switzerland
French
antivitamins K
journal article
anticoagulants
antivitamins K
vitamin K
acenocoumarol
indenes
4-hydroxycoumarins

---
http://www.lecofer.org/index.php?rub=2cycle&ssrub=cas
http://campus.cerimes.fr/rhumatologie/enseignement/rhumato27/site/html/
2009
true
2eme cycle / master
France
French
antivitamins K
anticoagulotherapy
French pre-residency program examination
rheumatology
anticoagulants
vitamin K
drug interactions
iatrogenic disease
hematoma
hematoma
signs and symptoms
medical history taking
hematoma
injections, Intra-Articular
injections, spinal
platelet aggregation inhibitors
hemarthrosis
acute disease
hemarthrosis
anticoagulants
anticoagulants
antivitamins K
educational course
case reports
indenes
4-hydroxycoumarins

---
http://lecrat.fr/spip.php?page=article&id_article=321
2009
France
French
clavulanic acid
beta-Lactamases
enzyme inhibitors
pregnancy
breast feeding
amoxicillin and enzyme inhibitor
ticarcillin and enzyme inhibitor
drug information

---
http://www.jle.com/fr/revues/bio_rech/jpc/e-docs/00/04/4D/17/resume.phtml?type=text.html
2009
France
English
French
antivitamins K
vitamin K
anticoagulants
anticoagulants
hemorrhage
comorbidity
drug interactions
hypertension
sex factors
age factors
international normalized ratio
amiodarone
proton pump inhibitors
warfarin
administration, oral
case-control studies
risk factors
emergency service, hospital
antivitamins K
antivitamins K
journal article
drug overdose
indenes
4-hydroxycoumarins

---
https://www.cadth.ca/fr/les-anti-tnf-dans-la-prise-en-charge-des-maladies-inflammatoires-chroniques-de-lintestin
https://www.cadth.ca/media/pdf/O0479_Anti_TNF_a_Drugs_for_Refractory_Inflammatory_Bowel_Disease_to_fr.pdf
2009
true
Canada
English
French
Adalimumab
Infliximab
tumor necrosis factor-alpha
Cost-Benefit analysis
drug costs
treatment outcome
gastrointestinal agents
gastrointestinal agents
crohn disease
proctocolitis
anti-inflammatory agents
anti-inflammatory agents
canada
randomized controlled trials as topic
patient care management
immunoglobulin G
receptors, tumor necrosis factor
drug evaluation
economic evaluation
comparative study

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2009/13327a-fra.php
2009
Canada
English
French
antirheumatic agents
neoplasms
tumor necrosis factor-alpha
child
drug labeling
pharmacovigilance note

---
http://ansm.sante.fr/var/ansm_site/storage/original/application/ae4209ebc36d7164d4b7c876ddeaabab.pdf
http://www.sfcardio.fr/sites/default/files/pdf/RBP_MTEV_Recommandations.pdf
2009
true
France
French
antivitamins K
anticoagulotherapy
venous thromboembolism
venous thrombosis
stockings, compression
heparin
heparin, low-molecular-weight
stroke
fibrinolytic agents
aspirin
intracranial hemorrhages
thrombosis
catheterization
neoplasms
venous thrombosis
pulmonary embolism
acute disease
ambulatory care
venous thromboembolism
anticoagulants
time
vitamin K
vena cava filters
anticoagulants
antivitamins K
antivitamins K
practice guideline
indenes
4-hydroxycoumarins

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F11F
2009
Belgium
Dutch
French
p-glycoprotein
drug interactions
cytochrome p-450 cyp3a
colchicine
journal article
pharmacovigilance note

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-10/firmagon_-_ct-6725.pdf
http://www.has-sante.fr/portail/jcms/c_928075/firmagon-degarelix-antagoniste-de-la-gnrh
2009
France
French
gonadotropin-releasing hormone
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
oligopeptides
insurance, health, reimbursement
degarelix
antineoplastic agents
injections, subcutaneous
treatment outcome
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
oligopeptides
prostatic neoplasms
neoplasms, hormone-dependent
antineoplastic agents
degarelix
degarelix
evaluation of the transparency committee
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_930285/erbitux-cetuximab-anticorps-monoclonal-anti-egfr-kras-sauvage
2009
false
France
French
guidelines for drug use
Cetuximab
receptor, epidermal growth factor
antineoplastic agents
infusions, intravenous
cetuximab
colorectal neoplasms
neoplasm metastasis
antineoplastic combined chemotherapy protocols
colorectal neoplasms
KRAS protein, human
proto-oncogene proteins
ras proteins
treatment outcome
survival rate
disease-free survival
evaluation of the transparency committee

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/4A/6A/resume.phtml?type=text.html
2009
France
French
journal article
carcinoma, hepatocellular
epidermal growth factor
receptor, epidermal growth factor
receptors, vascular endothelial growth factor
vascular endothelial growth factor a
carcinoma, hepatocellular
antibodies, monoclonal

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/52/0D/resume.phtml?type=text.html
2009
false
France
French
journal article
Cetuximab
Bevacizumab
antibodies, monoclonal
colorectal neoplasms
colorectal neoplasms
genes, ras
receptor, epidermal growth factor
panitumumab

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/52/13/resume.phtml
2009
France
French
journal article
antineoplastic agents
drug eruptions
folliculitis
receptor, epidermal growth factor

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/C8/resume.phtml?type=text.html
2009
France
French
journal article
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
receptor, epidermal growth factor
angiogenesis inhibitors

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/09/resume.phtml
2009
France
French
journal article
antibodies, monoclonal
carcinoma, non-small-cell lung
head and neck neoplasms
lung neoplasms
receptor, epidermal growth factor
receptor, erbB-2

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/0A/resume.phtml
2009
France
French
journal article
angiogenesis inhibitors
lung neoplasms
otorhinolaryngologic neoplasms
receptors, vascular endothelial growth factor
vascular endothelial growth factor a
antibodies, monoclonal

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/0B/resume.phtml
2009
France
French
journal article
head and neck neoplasms
intracellular signaling peptides and proteins
lung neoplasms
Protein-Serine-Threonine kinases
proto-oncogene proteins c-akt

---
http://www.cochrane.org/fr/CD003086
2009
France
French
Opioid withdrawal
meta-analysis
smoking cessation
opiate antagonist, nos
analgesics, opioid
treatment outcome
analgesics, opioid
french abstract

---
http://ansm.sante.fr/var/ansm_site/storage/original/application/5e41e9188c8a23330bc0f0461821d691.pdf
2009
France
French
antivitamins K
anticoagulants
anticoagulants
child
aged
anticoagulants
anticoagulants
drug interactions
pregnancy
anticoagulants
anticoagulants
vitamin K
antivitamins K
antivitamins K
vitamin k antagonists
guidelines for drug use
indenes
4-hydroxycoumarins

---
http://www.rmlg.ulg.ac.be/aboel.php?num_id=1699&langue=FR
2008
Belgium
French
rimonabant
piperidines
pyrazoles
receptor, cannabinoid, CB1
journal article

---
http://www.rmlg.ulg.ac.be/aboel.php?num_id=1790&langue=FR
2008
false
Belgium
French
Renin inhibitor (substance)
fumarates
aliskiren
amides
administration, oral
aliskiren
drug therapy, combination
antihypertensive agents
aliskiren
fumarates
amides
antihypertensive agents
renin
amides
fumarates
drug information
journal article

---
http://cemv.vascular-e-learning.net/poly/revisions/Autres/AVK/index.html
2008
false
true
false
false
France
antivitamins K
vitamin K
vitamin K
anticoagulants
hematology
anticoagulotherapy
French pre-residency program examination
audiovisual aids

---
http://www.has-sante.fr/portail/jcms/c_886848/spondylarthrites-traitement-et-suivi-argumentaire
http://www.has-sante.fr/portail/jcms/c_800266/diagnostic-prise-en-charge-therapeutique-et-suivi-des-spondylarthrites
http://www.has-sante.fr/portail/jcms/c_886846/spondylarthrites-diagnostic-argumentaire
2008
Haute Autorité de santé
France
French
adrenocortical steroid therapy
corticosteroid therapy
spondylarthritis
diagnostic imaging
consumer health information
pregnancy
spondylarthritis
spondylarthritis
spondylarthritis
spondylarthritis
anti-inflammatory agents, non-steroidal
adrenal cortex hormones
tumor necrosis factor-alpha
arthritis, psoriatic
continuity of patient care
severity of illness index
clinical trials as topic
retraction of publication
practice guideline
algorithms
economic evaluation
French pre-residency program examination
spondylarthritis

---
http://www.has-sante.fr/portail/jcms/c_745452/evaluation-de-lautosurveillance-de-linr-chez-les-patients-adultes-traites-par-antivitamines-k
2008
France
French
antivitamins K
adult
vitamin K
hemorrhage
international normalized ratio
international normalized ratio
anticoagulants
monitoring, ambulatory
anticoagulants
antivitamins K
antivitamins K
vitamin k antagonists
evaluation studies
indenes
4-hydroxycoumarins

---
https://www.revmed.ch/RMS/2008/RMS-143/Anticoagulation-orale-au-long-cours-indications-et-problemes
2008
true
Switzerland
French
anticoagulotherapy
vitamin K
time
atrial fibrillation
anticoagulants
venous thromboembolism
heart valve diseases
heart valve prosthesis implantation
continuity of patient care
anticoagulants
administration, oral
medication adherence
vitamin k antagonists
journal article

---
https://medicalforum.ch/fr/article/doi/fms.2008.06442/
2008
false
Switzerland
French
Renin inhibitor (substance)
renin
antihypertensive agents
journal article

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/3F/68/resume.md
2008
false
France
French
protein kinase C
protein kinase C
neoplastic processes
indoles
enzastaurin
aprinocarsen
staurosporine
phosphorothioate oligonucleotides
journal article

---
http://www.has-sante.fr/portail/jcms/c_682188/prise-en-charge-des-surdosages-des-situations-a-risque-hemorragique-et-des-accidents-hemorragiques-chez-les-patients-traites-par-antivitamines-k-en-ville-et-en-milieu-hospitalier
http://www.has-sante.fr/portail/jcms/c_682308/surdosage-en-avk-situations-a-risque-et-accidents-hemorragiques-document-destine-aux-medecins-generalistes
http://sfar.org/prise-en-charge-des-surdosages-en-antivitamines-k-des-situations-a-risque-hemorragique-et-des-accidents-hemorragiques-chez-les-patients-traites-par-antivitamines-k-en-ville-et-en-milieu-hospitalier/
http://sfar.org/?p=6761
2008
true
France
French
antivitamins K
anticoagulotherapy
general practitioners
vitamin K
drug overdose
hemorrhage
surgical procedures, operative
heparin
anticoagulants
anticoagulants
general practice
hemorrhage
patient care management
antivitamins K
antivitamins K
vitamin k antagonists
antivitamins K
practice guideline
indenes
4-hydroxycoumarins

---
http://www.minerva-ebm.be/fr/article/532
2008
minerva-ebm.be
Belgium
French
antivitamins K
aspirin
aspirin
treatment outcome
risk assessment
cardiovascular diseases
platelet aggregation inhibitors
vitamin K
anticoagulants
antivitamins K
drug therapy, combination
critical appraisal or critical reading
indenes
4-hydroxycoumarins

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F35F01H
2008
Belgium
French
antivitamins K
aged
anticoagulants
vitamin K
antivitamins K
vitamin k antagonists
journal article
indenes
4-hydroxycoumarins

---
http://www.meddispar.fr/medicaments/3553024
2008
France
French
gonadotropin-releasing hormone
injections, subcutaneous
drug prescriptions
legislation, drug
self administration
ganirelix
hormone antagonists
gonadorelin
gonadotropin-releasing hormone
drug information

---
http://lecrat.fr/spip.php?page=article&id_article=760
2007
France
French
pregnancy
breast feeding
receptors, cannabinoid
piperidines
pyrazoles
anti-obesity agents
rimonabant
rimonabant
piperidines
pyrazoles
drug information

---
http://revmed.ch/rms/2007/RMS-94/32000
2007
false
Switzerland
French
Ranibizumab
Bevacizumab
aptamers, nucleotide
prognosis
pegaptanib
macular degeneration
vascular endothelial growth factor a
intravitreal injections
visual acuity
agents for age related macular degeneration
drug information
journal article
image

---
http://revmed.ch/rms/2007/RMS-108/32229
2007
false
Switzerland
French
Omalizumab
anti-asthmatic agents
anti-allergic agents
asthma
asthma
receptors, ige
omalizumab
immunoglobulin e
journal article
drug information

---
http://www.revmed.ch/mh/Revue-medicale-suisse/2007/RMS-113/32315
2007
true
Switzerland
French
corticosteroid therapy
mineralocorticoid receptor antagonists
spironolactone
eplerenone
heart failure
receptors, mineralocorticoid
cardiovascular diseases
aldosterone
cardiovascular diseases
signal transduction
receptors, mineralocorticoid
eplerenone
journal article
drug information
diuretics, potassium sparing

---
http://www.revmed.ch/mh/Revue-medicale-suisse/2007/RMS-124/32419
2007
true
Switzerland
French
antivitamins K
administration, oral
anticoagulants
vitamin K
polymorphism, single nucleotide
CYP2C9 protein, human
aryl hydrocarbon hydroxylases
mixed function oxygenases
pharmacogenetics
vitamin k antagonists
antivitamins K
mixed function oxygenases
aryl hydrocarbon hydroxylases
journal article
drug information
indenes
4-hydroxycoumarins

---
http://cadth.ca/media/compus/reports/compus_Scientific_Report_final_f.pdf
2007
Canada
French
proton pump inhibitors
Evidence-Based medicine
gastroesophageal reflux
dyspepsia
peptic ulcer
helicobacter pylori
helicobacter infections
canada
zollinger-ellison syndrome
proton pump inhibitors
guideline
drug evaluation
table

---
http://www.has-sante.fr/portail/display.jsp?id=c_606483
http://www.has-sante.fr/portail/display.jsp?id=c_608766
2007
France
French
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
arthritis, rheumatoid
arthritis, rheumatoid
methotrexate
antirheumatic agents
glucocorticoids
tumor necrosis factor-alpha
anti-inflammatory agents, non-steroidal
phytotherapy
continuity of patient care
arthritis, rheumatoid
antibodies, monoclonal
immunoconjugates
interleukin 1 receptor antagonist protein
practice guideline
retraction of publication

---
http://www.jle.com/fr/revues/medecine/mca/e-docs/00/04/34/FB/article.md
2007
false
France
French
Renin inhibitor (substance)
renin
antihypertensive agents
hypertension
amides
fumarates
renin-angiotensin system
angiotensin-converting enzyme inhibitors
angiotensin II type 1 receptor blockers
heart failure
kidney diseases
drug evaluation, preclinical
journal article
comparative study

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F34F08H
2007
Belgium
French
tumor necrosis factor-alpha
receptors, tumor necrosis factor
arthritis, rheumatoid
antirheumatic agents
immunoglobulin G
antibodies, monoclonal
neoplasms
pharmacovigilance note
journal article

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2007/14479a-fra.php
2007
Canada
French
English
isoxazoles
isoxazoles
thiophenes
thiophenes
pregnancy
breast feeding
Chemical and Drug Induced Liver Injury
isoxazoles
thiophenes
hypertension, pulmonary
abnormalities, drug-induced
drug interactions
receptors, endothelin
isoxazoles
thiophenes
pharmacovigilance note

---
http://www.rhumatologie.asso.fr/Data/upload/images/RecoAntiTNF-PR_v2(1).pdf
2007
France
French
arthritis, rheumatoid
antibodies, monoclonal
antibodies, monoclonal
tumor necrosis factor-alpha
arthritis, rheumatoid
signs and symptoms
continuity of patient care
antibodies, monoclonal
tumor necrosis factor alpha (tnf-alpha) inhibitors
guidelines for drug use
table

---
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/resume.md?type=text.html
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/article.md?type=text.html
http://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/telecharger.md?code_langue=fr&format=application/pdf&titre=Version%20PDF
2006
France
French
antibodies, monoclonal
neoplasms
protein-tyrosine kinases
gastrointestinal stromal tumors
clinical trials as topic
antineoplastic agents
neoplastic processes
angiogenesis inhibitors
breast neoplasms
leukemia, myelogenous, chronic, bcr-abl positive
treatment outcome
journal article
HER-2 positive breast cancer

---
http://www.ansm.sante.fr/var/ansm_site/storage/original/application/ec94eda837a7c67a8faaa130b9f211dc.pdf
2006
France
French
immune tolerance
hemorrhage
factor IX
factor IX
hemophilia A
hemophilia B
factor VIII
hemophilia A
hemophilia A
hemophilia A
quality of life
factor VIII
factor VIII
factor VIII
factor VIII
risk factors
hemophilia A
factor VIII
factor VIII
continuity of patient care
technical report
guideline
table

---
http://www.sfcardio.fr/sites/default/files/pdf/reco_dentaires_avk.pdf
2006
true
France
French
antivitamins K
anticoagulotherapy
oral surgical procedures
blood loss, surgical
dental care for chronically ill
oral hemorrhage
vitamin K
risk assessment
anticoagulants
antivitamins K
vitamin k antagonists
patient care management
practice guideline
indenes
4-hydroxycoumarins

---
http://www.societechirorale.com/documents/Recommandations/recommandations_avk.pdf
2006
true
France
French
antivitamins K
anticoagulotherapy
vitamin K
anticoagulants
dentistry, operative
oral hemorrhage
risk assessment
oral surgical procedures
postoperative complications
hemostatic techniques
risk factors
international normalized ratio
antivitamins K
vitamin k antagonists
patient care management
practice guideline
indenes
4-hydroxycoumarins

---
http://www.revmed.ch/mh/Revue-medicale-suisse/2006/RMS-82/31727
2006
true
Switzerland
French
Adalimumab
Infliximab
tuberculosis
risk factors
tumor necrosis factor-alpha
leukopenia
arthritis, rheumatoid
infection
tumor necrosis factor alpha (tnf-alpha) inhibitors
immunoglobulin G
receptors, tumor necrosis factor
journal article
drug information

---
http://www.minerva-ebm.be/fr/article/637
2006
minerva-ebm.be
Belgium
French
weight loss
obesity
treatment outcome
piperidines
pyrazoles
cardiovascular diseases
risk factors
receptor, cannabinoid, CB1
adult
rimonabant
piperidines
pyrazoles
critical appraisal or critical reading

---
http://www.rmlg.ulg.ac.be/aboel.php?num_id=1440&langue=FR
2006
Belgium
French
proton pumps
time factors
gastroesophageal reflux
gastroesophageal reflux
costs and cost analysis
journal article

---
http://www.cadth.ca/media/pdf/E0006_aliskiren_edrug_f.pdf
2006
Canada
French
hypertension
renin
antihypertensive agents
angiotensin-converting enzyme inhibitors
aliskiren
drug evaluation

---
http://www.minerva-ebm.be/fr/article/792
2005
false
minerva-ebm.be
Belgium
French
Neuraminidase inhibitor (substance)
Evidence-Based medicine
enzyme inhibitors
treatment outcome
neuraminidase
influenza, human
sialic acids
acetamides
antiviral agents
critical appraisal or critical reading

---
http://www.rhumatologie.asso.fr/05-Bibliotheque/LeafletSpondylarthrite.pdf
2005
France
French
spondylitis, ankylosing
arthritis, psoriatic
tumor necrosis factor-alpha
spondylitis, ankylosing
arthritis, psoriatic
signs and symptoms
antibodies, monoclonal
tumor necrosis factor alpha (tnf-alpha) inhibitors
guidelines for drug use
algorithms

---
http://www.cadth.ca/media/pdf/163_glycoproteins_tr_f.pdf
https://www.cadth.ca/fr/les-inhibiteurs-des-recepteurs-la-glycoproteine-iib-iiia-etude-methodique-des-essais-cliniques
2005
true
Canada
French
myocardial infarction
antibodies, monoclonal
anticoagulants
platelet aggregation inhibitors
Cost-Benefit analysis
coronary stenosis
clinical trials as topic
canada
angioplasty, balloon, coronary
randomized controlled trials as topic
coronary disease
platelet aggregation inhibitors
platelet glycoprotein GPIIb-IIIa complex
myocardial ischemia
angina, unstable
myocardial infarction
eptifibatide
tirofiban
technical report
health technology assessment
drug evaluation
treatment outcome

---
http://www.rhumatologie.asso.fr/05-Bibliotheque/LeafletPolyarthrite.pdf
2005
France
French
arthritis, rheumatoid
drug utilization review
tumor necrosis factor-alpha
antibodies, monoclonal
arthritis, rheumatoid
signs and symptoms
antibodies, monoclonal
continuity of patient care
practice guideline

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-Tarceva_et_poumon_(2005-06).pdf
2005
false
false
Canada
French
English
Erlotinib Hydrochloride
protein kinase inhibitors
lung neoplasms
carcinoma, non-small-cell lung
lung neoplasms
carcinoma, non-small-cell lung
survival rate
lung neoplasms
carcinoma, non-small-cell lung
bibliography of medicine
Evidence-Based medicine
receptor, epidermal growth factor
quebec
erlotinib
graph
guidelines for drug use

---
http://www.has-sante.fr/portail/display.jsp?id=c_245349
2004
France
French
ribonucleotide reductases
neoplasms
antimetabolites, antineoplastic
zalcitabine
gemcitabine
gemcitabine
deoxycytidine
guidelines for drug use

---
http://www.cadth.ca/media/pdf/108_No42_adalimumab_edrug_f.pdf
2003
false
Canada
French
Adalimumab
Adalimumab
tumor necrosis factor-alpha
arthritis, rheumatoid
united states
canada
clinical trials as topic
drug evaluation

---
http://www.besancon-cardio.org/cours/55-anticoagulants-avk.php
2001
France
French
antivitamins K
anticoagulotherapy
cardiology
anticoagulants
anticoagulants
vitamin K
continuity of patient care
prothrombin time
international normalized ratio
anticoagulants
anticoagulants
hemorrhage
anticoagulants
embolism and thrombosis
embolism and thrombosis
heart valve prosthesis
pharmacology
atrial fibrillation
anticoagulants
Evidence-Based medicine
antivitamins K
antivitamins K
drug monitoring
vitamin k antagonists
educational course
practice guideline
indenes
4-hydroxycoumarins

---
http://www.cadth.ca/media/pdf/144_neuraminidase_cetap_f.pdf
http://www.cadth.ca/media/pdf/144_neuraminidase_cetap_e.pdf
2001
false
Canada
English
French
Neuraminidase inhibitor (substance)
neuraminidase
zanamivir
enzyme inhibitors
antiviral agents
influenza, human
oseltamivir
adult
treatment outcome
canada
Evidence-Based medicine
neuraminidase inhibitors
drug evaluation

---
http://www.sfcardio.fr/sites/default/files/pdf/reco9709.pdf
1997
true
France
French
antivitamins K
anticoagulotherapy
anticoagulants
anticoagulants
vitamin K
embolism
thrombosis
thrombosis
prothrombin time
heart valve prosthesis
myocardial ischemia
continuity of patient care
Evidence-Based medicine
embolism
heart valve diseases
pregnancy
antivitamins K
antivitamins K
vitamin k antagonists
guidelines
indenes
4-hydroxycoumarins

---
E-mail
24/10/2017


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.